Company: PTPI
Filing Date: 2025-01-24
Form Type: S-1
Source: 0001410578-25-000047
Chunk: 215

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-01-24
Form: S-1
Chunk 215
---
 2022. For the year ended December 31, 2022, the Company recognized a gain on the revaluation of the derivative liability of $ 0.5million.

11) Stock Options and Restricted Stock Units (“RSUs”) The Company established the 2020 Omnibus Incentive Compensation plan (the “2020 Plan”) which provides for the grants of awards to our directors, officers, employees, and consultants of 107,834. The 2020 Plan authorizes the grant of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards and cash-based awards. On December 22, 2021, our stockholders approved the Second Amendment to the 2020 Plan to increase the total number of shares of common stock issuable under the 2020 Plan by 152,166shares to a total of 260,000shares of common stock. On September 14, 2023, our stockholders approved the Third Amendment to the 2020 Plan to increase the total number of shares of common stock issuable under the 2020 Plan by 2,500,000shares to a total of 2,760,000shares of common stock. As of December 31, 2023, there were 2,760,000shares authorized and 2,158,658shares available for issuance under the 2020 Plan.

<div align='center'>F-20</div>

The following is a summary of stock options for the years ended December 31, 2023, and 2022:

| ​                                        
 ​                                        
 ​                                        
 ​                                        | ​ 
 ​ 
 ​ |                ​ 
                ​ 
                ​ 
 Number of Shares | ​ 
 ​ 
 ​ | ​                
 ​                
 Weighted-Average 
 Exercise Price   |      ​ | ​ 
 ​ 
 ​ |                     ​ 
      Weighted-Average 
 Remaining Contractual 
          Term (Years) | ​ 
 ​ 
 ​ | ​                   
 Aggregate Intrinsic 
 Value               
 ($ in thousands)    |  ​ |
|:-----------------------------------------|:--|-----------------:|:--|:-----------------|-------:|:--|----------------------:|:--|:--------------------|---:|
| Options outstanding at December 31, 2021 |   |           61,567 | ​ | $                |  33.80 |   |                  9.23 | ​ | $                   |  — |
|